SPY414.92-5.67 -1.35%
DIA332.96-5.20 -1.54%
IXIC14,030.38-130.97 -0.92%

Myovant Sciences Q4 EPS $(0.89) Beats $(0.99) Estimate, Sales $24.60M Miss $24.63M Estimate

Myovant Sciences (NYSE:MYOV) reported quarterly losses of $(0.89) per share which beat the analyst consensus estimate of $(0.99) by 10.1 percent. This is a 21.92 percent decrease over losses of $(0.73) per share from the

05/11/2021 06:58
Myovant Sciences (NYSE:MYOV) reported quarterly losses of $(0.89) per share which beat the analyst consensus estimate of $(0.99) by 10.1 percent. This is a 21.92 percent decrease over losses of $(0.73) per share from the same period last year. The company reported quarterly sales of $24.60 million which missed the analyst consensus estimate of $24.63 million by 0.12 percent.